感染症診断の市場規模、シェア、成長分析、製品タイプ別、検査タイプ別、サンプルタイプ別、疾患タイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

感染症診断市場規模は2023年に226億米ドルと評価され、予測期間（2025-2032年）のCAGRは7.6%で、2024年の243億2,000万米ドルから2032年には436億9,000万米ドルに成長する見通しです。

感染症診断市場は、感染症にかかりやすい高齢者人口の増加や早期診断をめぐる意識の高まりにより、成長が見込まれています。特に伝染病が流行する中、ポイントオブケア診断の需要がこの動向をさらに後押ししています。2022年までに65歳以上の高齢者は約7億7,900万人に達し、効果的な診断ソリューションの必要性が強調され、80歳以上の高齢者は2050年までに14億人を超えると予測されています。しかし、多くの地域で患者数が多いにもかかわらず、厳格な承認プロセスが市場成長の妨げになる可能性があるため、規制当局による監視の強化が課題となっています。感染性画像診断装置のような代替手段は存在するもの、体外診断の実証された精度と費用対効果は依然として非常に有利であり、市場での優位性を確実なものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 規制分析

感染症診断市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 試薬、キット、消耗品
• 機器
• ソフトウェアとサービス

感染症診断市場規模：検査タイプ別& CAGR（2025-2032）

• 市場概要
• 臨床検査
• POCテスト

感染症診断市場規模：サンプルタイプ別& CAGR（2025-2032）

• 市場概要
• 血液、血清、血漿
• 尿
• その他のサンプルタイプ

感染症診断市場規模：疾患タイプ別& CAGR（2025-2032）

• 市場概要
• 肝炎
  • B型肝炎
  • C型肝炎
  • その他の肝炎疾患
• HIV
• 院内感染
• 蚊媒介性疾患
• HPV
• クラミジア・トラコマティス
• 淋菌
• 結核
• インフルエンザ
• 梅毒
• その他の感染症

感染症診断市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 免疫診断
• 臨床微生物学
• ポリメラーゼ連鎖反応
• 等温核酸増幅技術
• DNAシーケンシングと次世代シーケンシング
• DNAマイクロアレイ
• その他のテクノロジー

感染症診断市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 診断検査室
• 病院と診療所
• 学術調査機関
• その他のエンドユーザー

感染症診断市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Abbott（US）
• bioMerieux（France）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Thermo Fisher Scientific Inc.（US）
• Hologic, Inc.（US）
• Becton, Dickinson and Company（US）
• Revvity（US）
• Qiagen（Netherlands）
• Seegene Inc.（South Korea）
• QuidelOrtho Corporation（US）
• Grifols, S.A.（Spain）
• DiaSorin S.p.A.（Italy）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• OraSure Technologies（US）
• Co-Diagnostics, Inc.（US）
• Trinity Biotech（Ireland）
• Genetic Signatures Ltd.（Australia）

結論と提言

Infectious Disease Diagnostics Market size was valued at USD 22.6 billion in 2023 and is poised to grow from USD 24.32 billion in 2024 to USD 43.69 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The market for infectious disease diagnostics is poised for growth due to a rising elderly population susceptible to infections and increased awareness surrounding early diagnosis. The demand for point-of-care diagnoses, particularly amid ongoing epidemics, further fuels this trend. By 2022, approximately 779 million individuals aged 65 and older emphasized the need for effective diagnostic solutions, with projections anticipating the number of those aged 80 and above will exceed 1.4 billion by 2050. However, increasing regulatory scrutiny poses challenges, as strict approval processes potentially hinder market growth despite the large patient pool in many regions. While alternatives like infectious imaging devices exist, the proven accuracy and cost-effectiveness of in vitro diagnostics remain highly favorable, ensuring their dominance in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infectious Disease Diagnostics Market Segments Analysis

Global Infectious Disease Diagnostics Market is segmented by Product, Type of Testing, Sample Type, Disease Type, Technology, End User and region. Based on Product, the market is segmented into Reagents, Kits, And Consumables, Instruments and Software & Services. Based on Type of Testing, the market is segmented into Laboratory Testing and POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-Acquired Infections, Mosquito-Borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis and Other Infectious Diseases. Based on Technology, the market is segmented into Immunodiagnostics,Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarray and Other Technologies. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infectious Disease Diagnostics Market

The growing incidence of infectious diseases such as HIV, tuberculosis, hepatitis, and COVID-19 is significantly propelling the demand for advanced diagnostic solutions worldwide. Effective treatment hinges on accurate and timely diagnosis, which is driving innovation in diagnostic technologies, including wearable injectors that integrate these advanced capabilities. Furthermore, the heightened focus on disease surveillance and outbreak monitoring is increasing the need for rapid, accessible diagnostics, thereby fostering market growth. As healthcare systems and organizations recognize the importance of early detection in managing infectious outbreaks, the infectious disease diagnostics market continues to expand in response to these critical healthcare challenges.

Restraints in the Infectious Disease Diagnostics Market

Despite advancements in technology, the prohibitive costs associated with advanced diagnostic tools and wearable injectors continue to pose a significant challenge. In many countries, particularly those classified as low- and middle-income, the affordability and availability of these diagnostic solutions remain major obstacles, hindering their widespread implementation. This financial challenge not only affects the growth of the Infectious Disease Diagnostics Market but also intensifies existing healthcare disparities, especially in regions with limited healthcare resources. Consequently, the inability to access effective diagnostics exacerbates the struggles faced by communities in managing infectious diseases effectively.

Market Trends of the Infectious Disease Diagnostics Market

The infectious disease diagnostics market is experiencing significant growth driven by the surge in Point-of-Care Testing (POCT). This trend is characterized by the decentralization of healthcare delivery, as rapid on-demand analysis and the convenience of portable diagnostic kits become integral to patient care. The ease of use and accessibility of these tests are facilitating increased patient attendance while alleviating pressure on hospitals by enabling outpatient testing. As healthcare systems prioritize efficiency and patient-centric solutions, the demand for innovative POCT solutions is expected to escalate, reshaping the landscape of infectious disease diagnostics and enhancing overall healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis

Global Infectious Disease Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents, Kits, And Consumables
• Instruments
• Software & Services

Global Infectious Disease Diagnostics Market Size by Type of Testing & CAGR (2025-2032)

• Market Overview
• Laboratory Testing
• POC Testing

Global Infectious Disease Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Infectious Disease Diagnostics Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
• HIV
• Hospital-Acquired Infections
• Mosquito-Borne Diseases
• HPV
• Chlamydia Trachomatis
• Neisseria Gonorrhea
• Tuberculosis
• Influenza
• Syphilis
• Other Infectious Diseases

Global Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• DNA Microarray
• Other Technologies

Global Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Academic Research Institutes
• Other End Users

Global Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Co-Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetic Signatures Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations